Precision Optics (NasdaqCM:POCI) Q2 2026 Earnings call February 17, 2026 05:00 PM ET Speaker1Good day, and welcome to the Precision Optics Reports second quarter fiscal year 2026 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on a touchtone phone. T ...

Financial Data and Key Metrics Changes - Total revenue for the full year 2025 was $329.5 million, a 12% increase year-over-year [4] - Full year gross margins expanded by 190 basis points year-over-year to 75.9% [5] - Adjusted EBITDA increased 21% year-over-year to $44.8 million [5] - Q4 total revenue grew by 21% year-over-year to $103.6 million [28] - Q4 gross margin was 78.2%, compared to 75.2% in Q4 2024 [28] - Net income increased by 9% to $10.6 million, or $0.46 per diluted share [30] Business Line Data and Key Metrics Changes - Lymphedema revenue increased 16% year-over-year to $89.5 million in Q4 [6] - Airway clearance revenue increased 66% year-over-year to $14.1 million in Q4 [6] - Sales and rentals of lymphedema products increased by $12.4 million, or 16% [28] - Sales of airway clearance products increased by $5.6 million, or 66% [28] Market Data and Key Metrics Changes - The company expects total revenue for 2026 to be in the range of $357 million to $365 million, representing year-over-year growth of 8% to 11% [6][31] - The Medicare channel remained strong in Q4, with patients moving directly to the Flexitouch Advanced pump under new NCD criteria [10] Company Strategy and Development Direction - The acquisition of LymphaTech is a significant milestone, expanding the company's capabilities in lymphedema solutions and enhancing R&D [8][15] - Strategic priorities include improving access to care, expanding treatment options, and enhancing lifetime patient value [9][25] - The company aims to leverage AI technology to improve order processes and operational efficiency [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the new Medicare prior authorization requirements, viewing them as a short-term headwind [31][46] - The company believes it is well-positioned to continue delivering growth in line with the overall lymphedema market [33] - Management highlighted the importance of ongoing investments in people and technology to support future growth [37] Other Important Information - The company ended 2025 with $83.4 million in cash and cash equivalents and generated close to $43 million in operating cash flow during the year [5] - The company has no outstanding borrowings as of the end of Q4 2025 [30] Q&A Session Summary Question: What drove the strong performance in the lymphedema business in Q4? - Management noted multiple investments in people, processes, and technology, including strong CRM adoption and increased sales rep productivity [41][42] Question: How do the new prior authorization requirements balance with the tailwinds from the NCD? - Management indicated that the guidance reflects a balanced approach, incorporating both tailwinds from the NCD and the headwinds from prior authorization [44][46] Question: Can you elaborate on the LymphaTech acquisition and its commercialization model? - Management expressed excitement about integrating LymphaTech into their commercial engine, focusing on measurement and surveillance for lymphedema [53][55] Question: What are the expectations for EBITDA margin growth moving forward? - Management indicated that while EBITDA margins are expected to grow modestly in 2026, long-term growth is anticipated as investments are completed [68]

Financial Data and Key Metrics Changes - Cadence reported a 14% revenue growth for Q4 2025, with total revenue reaching $1.44 billion for the quarter and $5.297 billion for the year [14][15] - The company achieved a 45% operating margin for the year, with a non-GAAP operating margin of 44.6% [4][15] - GAAP EPS was $1.42 for the quarter and $4.06 for the year, while non-GAAP EPS was $1.99 for the quarter and $7.14 for the year [15] Business Line Data and Key Metrics Changes - The core EDA business grew by 13% in 2025, driven by strong demand from AI and hyperscaler customers [9] - The IP business saw nearly 25% revenue growth in 2025, reflecting the strength of the expanding IP portfolio [11] - The hardware business had a record year with over 30 new customers and significantly higher repeat demand [9] Market Data and Key Metrics Changes - The company finished 2025 with a record backlog of $7.8 billion, indicating strong demand across all business lines [4][14] - China accounted for approximately 12%-13% of revenue in 2025, with expectations to maintain this range in 2026 [28] Company Strategy and Development Direction - Cadence is focusing on AI-driven solutions, emphasizing the integration of AI into their engineering software to enhance design exploration and accelerate time to market [5][6] - The company is expanding partnerships with leading foundries, including TSMC and Intel, to develop next-generation AI flows [8] - The strategic collaboration with Broadcom aims to develop pioneering agentic AI workflows for next-generation products [6][8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing demand for EDA tools, stating that AI tools are increasing the usage of their software rather than displacing it [24] - The outlook for 2026 includes expected revenue in the range of $5.9 billion to $6 billion, with a strong emphasis on recurring revenue growth [16][17] - Management highlighted a healthier environment for the semiconductor industry in 2026 compared to the previous year, with broad-based strength across various sectors [60][61] Other Important Information - The company is actively applying AI internally to improve efficiency across engineering, go-to-market, and operations [8] - Cadence launched several new products, including the ChipStack AI Super Agent, which provides significant productivity improvements for chip design tasks [5][12] Q&A Session Summary Question: Disruption in AI affecting demand for EDA tools - Management clarified that there has been no discussion from customers about reducing the use of EDA tools due to AI; instead, AI is increasing the usage of their tools [24] Question: Outlook for 2026 and recurring revenue improvements - Management indicated that strong backlog supports expectations for recurring revenue growth, with 67% of 2026 revenue coming from beginning backlog [29] Question: Verification and emulation hardware cycle - Management expects continued strong demand for hardware systems, emphasizing their importance in designing complex chips [33] Question: Benefits of AI workflows for customers - Management reported significant productivity improvements for customers using AI, with examples of 4x and 7-10x productivity gains [41][42] Question: Transition to one-year license terms for SDA - Management acknowledged that moving to annual subscription arrangements impacted year-over-year numbers but remains optimistic about SDA's growth trajectory [49] Question: COT proliferation among hyperscaler customers - Management noted that the trend of hyperscalers designing their own chips is accelerating, with expectations for increased COT adoption [56][57]

Axcelis Technologies (NasdaqGS:ACLS) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Speaker9Good day, ladies and gentlemen, and welcome to the Axcelis Technologies call to discuss the company results for the fourth quarter and full year 2025. My name is Victor, and I'll be your coordinator for today. I'd like to turn the presentation over to your host for today's call, David Ryzhik, Senior Vice President of Investor Relations and Corporate Strategy. Please proceed.Speaker3Thank you, operator. This is D ...

SSR Mining (NasdaqGS:SSRM) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Speaker6Hello everyone, and welcome to SSR Mining's fourth quarter and full year 2025 financial results conference call. This call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Alex Hunchak from SSR Mining. Please go ahead.Speaker0Thank you, operator, and hello everyone. Thank you for joining today's conference call to discuss SSR Mining's fourth quarter and full yea ...

The Hackett Group (NasdaqGS:HCKT) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Speaker2Welcome to the Hackett Group fourth quarter earnings conference call. Your lines have been placed on a listen-only mode until the question and answer session. Please be advised the conference is being recorded. Hosting tonight's call are Mr. Ted Fernandez, Chairman and CEO, and Mr. Rob Ramirez, Chief Financial Officer. Mr. Ramirez, you may begin, sir.Speaker3Good afternoon, everyone, and thank you for joining us to ...

Cineverse (NasdaqCM:CNVS) Q3 2026 Earnings call February 17, 2026 04:30 PM ET Company ParticipantsChris McGurk - Chairman and CEOErick Opeka - President and Chief Strategy OfficerGary Loffredo - Chief Legal Officer and Senior AdvisorMark Lindsey - CFOTony Huidor - President of Technology and Chief Product OfficerConference Call ParticipantsBrian Kinstlinger - Equity Research AnalystDan Kurnos - Equity Research AnalystLaura Martin - Equity Research AnalystOperatorGood day, everyone, and thank you for joining ...

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $105.3 million, up 12% year-over-year, and $365.3 million for the full year, growing 16% [30] - Adjusted EBITDA for Q4 grew 5% to $39.2 million, with a full year adjusted EBITDA of $113.6 million, growing 14% and producing an adjusted EBITDA margin of 31% [33] - Total written premiums for Q4 were $1.1 billion, growing 13% year-over-year, and $4.4 billion for the full year, up 17% over 2024 [32] Business Line Data and Key Metrics Changes - Core revenues for Q4 grew 15% to $78.2 million, and for the full year, they grew 16% to $317.9 million due to improved client retention and new business production [30] - Policies in force grew 14% to 1.9 million, accelerating from a 13% growth rate in Q3 2025 [33] - Gross payments per franchise increased by 29% year-over-year, indicating improved cash flow for franchise owners [11] Market Data and Key Metrics Changes - The company is transitioning out of a hard market where carriers raised rates and tightened underwriting, leading to improved underwriting profitability and a healthier product market [9] - The corporate agents outside of Texas increased from 30% in 2022 to 52% in 2025, indicating geographic expansion [13] Company Strategy and Development Direction - The company aims to accelerate growth within existing agencies, expand corporate sales, and invest in technology, particularly AI applications [18] - Goosehead is focused on maintaining a long-term mindset and prioritizing quality over quantity in its franchise network, which has led to increased productivity and healthier economics [22] - The Digital Agent 2.0 platform is a key strategic initiative, providing an end-to-end choice buying experience and enhancing client interactions [15][26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position for 2026, expecting low double-digit core revenue growth in the first half and acceleration in the second half as market conditions improve [31] - The company acknowledges the potential impact of regulatory changes on the insurance pricing environment but remains optimistic about its ability to adapt [42][44] - Management believes that AI will enhance agent productivity rather than disintermediate them, as the complexity of home insurance requires human interaction [48][50] Other Important Information - The company repurchased and retired 323,000 shares of Class A stock in Q4, totaling $22.5 million, with an additional $180 million share repurchase authorization announced [35][36] - Cash flow from operations for the year was $91.8 million, up 28% from the prior year, indicating strong cash generation capabilities [34] Q&A Session Summary Question: Guidance for next year regarding home closing transactions and insurance pricing environment - Management noted that housing construction has not been a significant headwind and that they do not expect improvements in housing to impact guidance for 2026 [40] - Pricing dynamics are expected to vary, with the bottom end of guidance assuming generally down pricing and the top end including moderate increases [41] Question: Impact of regulatory changes on business model - Management expressed uncertainty about the likelihood of profitability caps but noted that the Excess and Surplus Lines market may be more durable in such scenarios [44] Question: Use of AI and disintermediation of agents - Management believes that the complexity of home insurance will prevent disintermediation, as clients still prefer human guidance [48][50] Question: Digital Agent 2.0 platform and customer retention - Initial results indicate that the platform improves client retention by allowing existing clients to purchase additional policies [53] Question: Investment spending in 2026 - Management expects total cash investment spending in 2026 to be between $25 million and $35 million, with a portion impacting the P&L [65] Question: Producer trends and franchise consolidation - Management anticipates continued demand for new hires and expects producer counts to increase as consolidation occurs [77][79]

Medifast (NYSE:MED) Q4 2025 Earnings call February 17, 2026 04:30 PM ET Company ParticipantsDan Chard - Chairman and CEOJim Maloney - CFONick Johnson - PresidentSteven Zenker - VP of Investor RelationsConference Call ParticipantsJim Salera - Research AnalystOperatorGreetings, and welcome to the Medifast fourth quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. Should anyone require operator ...

Financial Data and Key Metrics Changes - Adjusted EBITDA increased by 10% on a 4% increase in gross transaction value (GTV) in Q4 2025, reflecting strong execution and cost management [4][11] - Adjusted earnings per share increased by 17% in Q4 and 15% for the full year, driven by higher operating income and lower net interest expense [14] - Full-year GTV increased by 2%, driven by new wins in the automotive sector, partially offset by cyclical pressure in the commercial construction and transportation (CC&T) sector [12][14] Business Line Data and Key Metrics Changes - Automotive GTV increased by 3% in Q4, with unit volumes rising by 2%. Excluding catastrophic impacts, GTV and unit volumes grew approximately 12% and 8%, respectively [11][12] - In the CC&T sector, GTV increased by 9%, with unit volumes growing approximately 10% and average price per lot sold increasing due to improvements in asset mix [12][14] Market Data and Key Metrics Changes - Gross returns or salvage values as a percentage of pre-accident cash values expanded, supporting approximately 7% year-over-year growth in the U.S. insurance average selling price [6] - The inflation differential between automotive repair costs and used vehicle pricing continued to narrow, supporting an increase in the total loss ratio [11] Company Strategy and Development Direction - The company is focused on disciplined execution and strategic progress, prioritizing scale, longevity, and strategic positioning to expand market share and enhance partner relationships [4][5] - A new multi-year agreement with one of the largest partners was signed, reinforcing trust and providing long-term visibility into expected volumes [5][6] - The company plans to roll out the IAA Total Loss Predictor in 2026 to improve vehicle routing efficiency, which is expected to deliver cost savings for partners [8] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding early signs of improvement in seller confidence within the CC&T sector, supported by stabilizing used equipment values and lower interest rates [9] - The outlook for 2026 anticipates full-year GTV growth between 5% and 8%, with a focus on volume-led growth and continued market share gains [15] Other Important Information - The company expects full-year capital expenditures for 2026 to be between $350 million and $400 million, with a mix of one-third on technology-related investments and two-thirds on traditional physical assets [15][38] - The company is committed to ongoing operational excellence and cost savings initiatives to maximize profit flow-through [15][47] Q&A Session Summary Question: Clarification on 2026 guidance and market share capture - Management confirmed that the guidance includes annualization of wins already announced and any additional terms agreed upon [20] Question: Flow-through of GTV to revenue - Management indicated there may be slight pressure on the take rate but remains optimistic about unit economics and volume growth [22] Question: Improvement in CC&T sector - Management noted early signs of improvement in partner conversations, indicating potential for a return to a normalized cycle [26] Question: Details on the total loss predictor - The total loss predictor aims to enhance efficiency by determining vehicle status at the scene of an accident, potentially reducing costs associated with storage and rental fees [28] Question: AI development among competitors - Management acknowledged varying capabilities among insurance carriers regarding AI development, emphasizing their role in providing integrated solutions [35] Question: Capital allocation strategy - Management is focused on debt reduction, business investment, and evaluating share repurchase opportunities as part of their capital allocation strategy [53] Question: Impact of autonomous vehicles - Management does not foresee immediate risks from autonomous vehicles but acknowledges potential long-term changes in collision rates and vehicle ownership [57] Question: Total salvage volumes outlook - Management expects to continue gaining market share and growing faster than the market, without providing specific volume breakdowns [78]